The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

The CDDF Community

 

 

Join the CDDF community: working together to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

 

The CDDF has developed a community of stakeholders who support a shared mission to facilitate debate and progress in the field of oncology drug development. Non-commercial organisations (academia, NGOs and associations), pharmaceutical companies, regulatory agencies and individuals in the community of cancer research can become part of the collaborative CDDF network. The CDDF believes that collaboration plays a crucial role in overcoming challenges in the development of cancer drugs. By establishing a multi-stakeholder network and working together constructively we can achieve our goal to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.

We thank CDDF members and partners for their ongoing support.

REGULATORY AUTHORITIES

The CDDF collaborates with representatives from regulatory authorities to access their viewpoint on drug development.

PHARMACEUTICAL INDUSTRY PARTNERS

CDDF pharmaceutical industry partners provide the industry perspective on challenges to be addressed in cancer drug development.

ORGANISATIONS

The CDDF cooperates closely with the following organisations whose missions are in alignment with the CDDF’s.

PATIENT ADVOCACY GROUPS

The CDDF works closely with patient advocacy groups to incorporate patient perspectives into the discussion.

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70